Combination therapy with tofacitinib and minoxidil for Bjornstad syndrome caused by novel BCS1L gene variants
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2026-07 · 24 (7)
DOI: 10.1111/ddg.70002x ↗Kurz gefasst
Fallbericht in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 12.03.2026. Verfasst von Xiaoxian Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Hospital of Shandong First Medical University, Jinan, China. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Hospital of Shandong First Medical University, Jinan, China.
- Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, China.
- China-Japan Friendship Hospital, Beijing, China.
- Shandong University of Traditional Chinese Medicine, Jinan, China.
ORCID-Profile: Xiaoxian Li
Zitieren
APA
Li, X., Yang, D., Wang, Z., Chen, X., & Liu, G. (2026). Combination therapy with tofacitinib and minoxidil for Bjornstad syndrome caused by novel BCS1L gene variants. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 24(7). https://doi.org/10.1111/ddg.70002x
Vancouver
Li X, Yang D, Wang Z, Chen X, Liu G. Combination therapy with tofacitinib and minoxidil for Bjornstad syndrome caused by novel BCS1L gene variants. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2026;24(7). doi:10.1111/ddg.70002x
BibTeX
@article{Li2026,
author = {Li, Xiaoxian and Yang, Dingquan and Wang, Zhenzhen and Chen, Xi and Liu, GuoYan},
title = {Combination therapy with tofacitinib and minoxidil for Bjornstad syndrome caused by novel BCS1L gene variants},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2026},
volume = {24},
number = {7},
doi = {10.1111/ddg.70002x}
}
EUVIMED